Admin

Innovative Chinese medicine makes another breakthrough abroad! Hansoh Pharmaceutical signs a licensing agreement with Roche for a colorectal cancer drug, valued at up to $1.45 billion.

Innovative Chinese medicine makes another breakthrough abroad! Hansoh Pharmaceutical signs a licensing agreement with Roche for a colorectal cancer drug, valued at up to $1.45 billion.

``` Chinese innovative pharmaceutical company Hansoh Pharma has reached a licensing agreement with Swiss pharmaceutical giant Roche, granting it the overseas rights to a new investigational anti-cancer drug, highlighting the increasingly important role of Chinese biotechnology in the global innovation landscape. According to Hansoh Pharma's announcement on October 17,
Admin